Formula Growth’s DexCom DXCM Stock Holding History

Formula Growth’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$926K	Sell	13,744 -112	-0.8%	-$7.46K	0.33%	108
2026 Q1	$870K	Sell	13,856 -190	-1%	-$13.2K	0.39%	89
2025 Q4	$932K	Sell	14,046 -23,487	-63%	-$1.52M	0.36%	98
2025 Q3	$2.53M	Sell	37,533 -10,000	-21%	-$791K	0.9%	50
2025 Q2	$4.15M	Sell	47,533 -10,820	-19%	-$848K	1.57%	13
2025 Q1	$3.98M	Buy	58,353 +10,205	+21%	+$833K	1.62%	10
2024 Q4	$3.74M	Buy	48,148 +22,600	+88%	+$1.67M	1.27%	28
2024 Q3	$1.71M	Sell	25,548 -180	-0.7%	-$14.8K	0.59%	70
2024 Q2	$2.92M	Buy	25,728 +4,670	+22%	+$590K	1.06%	34
2024 Q1	$2.92M	Sell	21,058 -742	-3%	-$93.3K	0.93%	46
2023 Q4	$2.71M	Buy	+21,800	New	+$2.23M	0.87%	51
2017 Q3	–	Sell	-84,000	Closed	-$1.54M	–	136
2017 Q2	$1.54M	Hold	84,000	–	–	0.26%	97
2017 Q1	$1.78M	Buy	84,000 +20,000	+31%	+$390K	0.37%	84
2016 Q4	$955K	Buy	+64,000	New	+$1.13M	0.22%	107

Other funds holding DXCM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Formula Growth's DXCM Position: Q2 2026 in Review

Formula Growth reduced its DexCom (DXCM) stake by 0.81% in Q2 2026, selling an estimated $7.46K and leaving 13,744 shares worth $926K. The position accounts for 0.33% of the portfolio, ranked #108.

Formula Growth first reported a position in DXCM in Q4 2016 and has held it in 14 quarters since. The position peaked at $4.15M in Q2 2025. 971 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

Formula Growth held 13,744 shares of DexCom worth $926K as of Q2 2026.
Formula Growth sold 112 DexCom shares in Q2 2026, an estimated $7.46K.
DexCom made up 0.33% of Formula Growth's portfolio in Q2 2026, its #108 holding.
Formula Growth first reported a position in DexCom in Q4 2016 and has held it in 14 quarters since.
Formula Growth's DexCom position peaked at $4.15M in Q2 2025.
971 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Formula Growth's 13F filing for Q2 2026, filed 17 Aug 2026.